Baker Joffre 4
4 · GENOMIC HEALTH INC · Filed Dec 9, 2009
Insider Transaction Report
Form 4
Baker Joffre
Chief Scientific Officer
Transactions
- Sale
Common Stock
2009-12-08$20.26/sh−4,629$93,806→ 154,749 total
Holdings
- 66,343(indirect: By Trust)
Common Stock
- 36,113(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on December 5, 2006.
- [F2]Represents weighted average sale price. Actual sale prices ranged from $20.17 to $20.35.
- [F3]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- [F4]The reporting person also continues to indirectly own 66,343 shares of GHDX common stock held by the Joffre and Diana J. Baker 1998 Trust, of which the reporting person and his wife are trustees and beneficiaries. The reporting person continues to report beneficial ownership of all of the GHDX common stock held by the Joffre and Diana J. Baker 1998 Trust, but disclaims beneficial ownership except to the extent of his pecuniary interest therein.
- [F5]The reporting person continues to indirectly own 36,113 shares of GHDX common stock held by the Baker Family Charitable Remainder Trust, of which the reporting person and his wife are trustees and beneficiaries. The reporting person continues to report beneficial ownership of all of the GHDX common stock held by the Baker Family Charitable Remainder Trust, but disclaims beneficial ownership except to the extent of his pecuniary interest therein.